Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Amortizatization of Intangibles (2021 - 2025)

Historic Amortizatization of Intangibles for Ascendis Pharma A (ASND) over the last 5 years, with Q3 2025 value amounting to $143793.8.

  • Ascendis Pharma A's Amortizatization of Intangibles rose 1385.53% to $143793.8 in Q3 2025 from the same period last year, while for Sep 2025 it was $530834.1, marking a year-over-year decrease of 164.62%. This contributed to the annual value of $505452.0 for FY2024, which is 273.77% down from last year.
  • As of Q3 2025, Ascendis Pharma A's Amortizatization of Intangibles stood at $143793.8, which was up 1385.53% from $134703.2 recorded in Q2 2025.
  • In the past 5 years, Ascendis Pharma A's Amortizatization of Intangibles ranged from a high of $161391.0 in Q4 2023 and a low of $111918.5 during Q3 2022
  • Moreover, its 5-year median value for Amortizatization of Intangibles was $126295.2 (2024), whereas its average is $127693.6.
  • As far as peak fluctuations go, Ascendis Pharma A's Amortizatization of Intangibles skyrocketed by 4251.18% in 2023, and later crashed by 2120.82% in 2024.
  • Quarter analysis of 5 years shows Ascendis Pharma A's Amortizatization of Intangibles stood at $128124.8 in 2021, then decreased by 11.61% to $113247.5 in 2022, then skyrocketed by 42.51% to $161391.0 in 2023, then fell by 21.21% to $127162.8 in 2024, then grew by 13.08% to $143793.8 in 2025.
  • Its Amortizatization of Intangibles was $143793.8 in Q3 2025, compared to $134703.2 in Q2 2025 and $125174.2 in Q1 2025.